CONMED Corporation Announces Second Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/10/2026
- S&P 500 ends down as oil tops $100 per barrel
- Trump promises $5,000 payout to U.S. adults if Republicans win election
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Rogers adds Sportsnet+ content to Xfinity TV packages for free
- AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
CONMED (CNMD) PT Raised to $83 at Needham & Company
August 2, 2018 6:43 AM EDTNeedham & Company raised its price target on CONMED (NASDAQ: CNMD) to $83.00 (from $73.00) while maintaining a Buy rating.
Analyst Mike Matson commented, "CNMD's 2Q18 revenue and EPS beat consensus and management raised its 2018 revenue and maintained its EPS guidance. Revenue growth improved... More
Conmed (CNMD) Tops Q2 EPS by 1c; Raises Outlook
August 1, 2018 4:14 PM EDTConmed (NASDAQ: CNMD) reported Q2 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the quarter came in at $212.8 million versus the consensus estimate of $207.12 million.
GUIDANCE:
Conmed sees FY2018 EPS of $2.15-$2.20, versus the consensus of $2.17.
For earnings history and earnings-related data on Conmed (CNMD) click here.
... More